Trametinib Plus Anlotinib in Non-G12C KRAS-Mutant NSCLC Patients
Clinical trial NCT04967079 · COMPLETED
Trial details
- NCT number
- NCT04967079
- Sponsor
- Shanghai Chest Hospital
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-01
- Primary completion
- 2023-07-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.